More than 400 international experts, professionals, innovators, managers, startuppers and investors gathered to discuss and outline the future of digital health.
While in the United States the Food and Drug Administration (FDA) approved the first digital pill with a tracking system able to verify the course of therapy, marking a new dimension in the field of digital therapies, Berlin was about to welcome people coming from all over the world to discuss digital health in the fantastic scenario of AXICA.
Between 16 and 17 November 2017 , the event has catalyzed the attention of professionals in the pharmaceutical sector, venture capitalists, startups, insurance companies , who have had the opportunity to share their vision, insights and experiences on the subject of Health, as we will live it tomorrow (but we are learning to know already from today!). The interconnected and flexible nature of the dynamics underlying and reinforcing the revolution in this sector emerges strongly and the conviction that the growing and uninterrupted integration of medicine and technology is destined to profoundly transform the paradigms on which traditional methods of diagnosis, prevention and care.
New trends in the medical field
For its second edition, the conference has chosen as its motto ” where health meets innovation “, And we can not but agree since the era of convergence towards Health is helping to bring together two strategic sectors, such as medicine and technology, creating new opportunities and trends, such as health-oriented technologies, digital therapies and plans. personalized insurance.
A unique platform
The Conference Chairman, Roberto Ascione he claims:
Frontiers Health has quickly become one of the leading international conferences on digital health, thanks to the unique mix of participants and speakers (investment funds, life science companies, innovative hubs, insurance companies, startups), offering a unique platform for discussing how innovations in different fields are converging, thus transforming the health sector. Any success story born from the conference will be an excellent result for each of the participants who will have actively contributed to this extraordinary journey
Themes and speaker
Among the main topics discussed, we highlight that of the Digital Therapies , with the presence of more than 30 companies active in this field and an entire session dedicated to the recent launch of the Digital Therapeutics Alliance (DTA) whose members ( Pierre Leurent , CEO Voluntis, Anand Iyer , Chief Strategy Officer WellDoc, e Vincent Hennemand , VP of Strategy, Corporate & BD Akili Interactive) illustrated the changes taking place, the opportunities for healthcare providers and the pharmaceutical industry and the commitment to defining treatment protocols and clinical efficacy data, thanks to what is called the third phase of medicine.
In the session Transforming Pharma , introduced by Paul Tunnah – CEO pharmaphorum media, some of the leading companies in the pharmaceutical sector have presented their respective digital transformation strategies: Francesco Acanfora , Head of Digital Innovation and Services, MENARINI Group; Eugene Borukhovich, Global Head, Digital Health Innovation, Bayer; Fiona Cook , Senior Manager, Global Corporate Responsibility Programs & Steffen Kurzawa, Global Head Communications & Member of the Sandoz Executive Committee, Sandoz International; Lana Ghanem , Managing Director, Hikma Ventures and John Gordon , Head of Digital, Internal Medicine, International Developed Markets, Pfizer Ltd.
Among the top speakers of this edition: Jeff Dachis , Founder & CEO, One Drop, Indra Ioshi , Clinical Lead for NHS England, Mariarosaria Taddeo , Research Fellow, Oxford Internet Institute, Bart van der Sloot , Senior Researcher, Tilburg Institute for Law, Technology and Society (TILT) e Francesca Fedeli and Roberto D’Angelo , Founders FightTheStroke.
Article published on healthwareinternational.com in English